Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut ...

Purdue Pharma has filed a new reorganization plan that aims to deliver more than $7.4 billion in cash to creditors, subject to certain reserves, to compensate victims and abate the opioid crisis.

STAMFORD, Conn., March 19, 2025--Purdue Pharma L.P. ("Purdue") today filed a Chapter 11 Plan of Reorganization (the "Plan") and related disclosure statement with the United States Bankruptcy Court ...

Purdue Pharma bankruptcy plan, ... 2007, file photo, the Purdue Pharma logo is shown on the headquarters building ... New York, allowed Purdue to begin soliciting support for its Chapter 11 ...

Purdue Pharma L.P. today filed a Chapter 11 plan of reorganization (the Plan) and a related disclosure statement in the United States Bankruptcy Court ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

Meanwhile, the U.S. trustee issued a formal objection to the plan. The Justice Department said Monday it has "fundamental concerns" with Purdue Pharma’s plan to exit Chapter 11 bankruptcy ...

Commentary In Defense of Purdue Pharma's Bankruptcy Plan Simply put, it will save lives. September 01, 2021 at 01:41 PM ...

The U.S. Justice Department is condemning a proposed bankruptcy settlement for Purdue Pharma, the maker of Oxycontin. In court filings Monday, two divisions of the DOJ described the plan as ...

A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states ...

NEW YORK (Reuters) -Bankrupt drugmaker Purdue Pharma filed a new bankruptcy plan on Tuesday, a major step towards finalizing a proposed opioid settlement of at least $7.4 billion after a setback ...